Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARS: TBO-309 in Acute Ischaemic Stroke
NCT05363397Phase 2Recruiting
- Sponsor
- Florey Institute of Neuroscience and Mental Health
- Start
- Sep 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AZD-6482 in ischemic stroke, sponsored by Florey Institute of Neuroscience and Mental Health. Started Sep 2023; status: recruiting.
02
Drugs
AZD-6482
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05363397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05363397.